June 2020 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for June 2020. This roundup includes...
Comparative Effectiveness of Treatments Explored in T2DM
Greatest drop in HbA1c for insulin, specific glucagon-like peptide-1 receptor agonist added to metformin
Global Burden of Thyroid Cancer Is Increasing
Burden higher among women, Southern and Eastern Asia, with one-third of cases in wealthy nations
Government E-Cigarette Restrictions on Marketing Lower Use
Findings among repeated surveys of 16 to 19-year-olds in Canada
CDC Updates List of Who Is at Highest Risk for COVID-19
Agency now says risk among adults increases steadily with age, and is not limited to those over 65
Heart Failure Ups Risk of Death in Patients With New T2DM
Five-year risk ratio of death linked to heart failure three times higher at five years after T2DM diagnosis
Women Have More Brain Changes Related to Alzheimer Disease
Menopausal status the predictor most consistently and strongly linked to brain differences, after sex
Trump Administration Asks Supreme Court to Overturn Affordable Care Act
Oral arguments in the ACA case are scheduled for the Supreme Court's next term
Administrative Data Predict Mortality With Diabetes
Thirty-seven factors have good accuracy for predicting five- and 10-year mortality in older veterans
Metabolic Syndrome Up in Young Adults in the United States
Significant increases between 2011 and 2016 also seen for women, Asians, and Hispanics
